0001209191-16-136460.txt : 20160810
0001209191-16-136460.hdr.sgml : 20160810
20160810192838
ACCESSION NUMBER: 0001209191-16-136460
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160808
FILED AS OF DATE: 20160810
DATE AS OF CHANGE: 20160810
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AxoGen, Inc.
CENTRAL INDEX KEY: 0000805928
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411301878
STATE OF INCORPORATION: MN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13859 PROGRESS BLVD.
STREET 2: SUITE 100
CITY: ALACHUA
STATE: FL
ZIP: 32615
BUSINESS PHONE: (386) 462-6817
MAIL ADDRESS:
STREET 1: 13859 PROGRESS BLVD.
STREET 2: SUITE 100
CITY: ALACHUA
STATE: FL
ZIP: 32615
FORMER COMPANY:
FORMER CONFORMED NAME: LECTEC CORP /MN/
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mandato Joseph M
CENTRAL INDEX KEY: 0001375003
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36046
FILM NUMBER: 161822657
MAIL ADDRESS:
STREET 1: DE NOVO VENTURES
STREET 2: 1515 EL CAMINO REAL, #150
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-08
0
0000805928
AxoGen, Inc.
AXGN
0001375003
Mandato Joseph M
14612 BIG BASIN WAY
SARATOGA
CA
95070
1
0
0
0
Common Stock
2016-08-08
4
S
0
107450
8.63
D
1268941
I
By De Novo Ventures II, L.P.
Common Stock
2016-08-09
4
S
0
42168
8.30
D
1226773
I
By De Novo Ventures II, L.P.
Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $8.50 and $8.67 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The Form 4 filed with the SEC on June 3, 2015 over reported the amount of securities beneficially owned following the reported transaction by one share, which has been corrected in this filing.
The shares are owned by De Novo Ventures II, L.P. ("DNV II"). De Novo Management II, LLC is the sole general partner of DNV II. The reporting person is a managing member of De Novo Management II, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Price reflected is the weighted-average sale price for shares sold. The range of the sale prices for the transaction was $8.27 and $8.34 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Joseph M. Mandato
2016-08-10